IL1B and osteoarthritis: One example of a disease-modifying osteoarthritis-drug (DMOAD) based on blocking the intraarticular effects of IL-1 associated with OA, is autologous conditioned serum (ACS or Orthokine®; Orthogen, Düsseldorf, Germany).